Perthera Inc Press Releases

• Published on January 23, 2025 - 14:23 GMT

  Perthera to Present Research Validating World’s First AI-Driven Chemo Predictor at 2025 ASCO GI Cancers Symposium

  MCCLEAN, VA, UNITED STATES, January 23, 2025 /⁨EINPresswire.com⁩/ -- Perthera, a leader in precision oncology, will present follow-on research and validation of the world’s first AI-driven chemo predictor for frontline treatment in pancreatic cancer (PDAC) …

  Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
• Published on January 14, 2025 - 17:26 GMT

  Perthera Announces Breakthrough in Pancreatic Cancer, World’s First AI-Driven Chemo Predictor for Frontline Treatment

  MCCLEAN, VA, UNITED STATES, January 14, 2025 /⁨EINPresswire.com⁩/ -- Perthera, a leader in AI-driven precision oncology, announces a groundbreaking advancement in the fight against pancreatic adenocarcinoma (PDAC) with the introduction of PDACai, the world …

  Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
• Published on December 19, 2024 - 20:50 GMT

  Latest Perthera Report Further Advances AI-Powered Support for Personalized Cancer Therapies

  MCCLEAN, VA, UNITED STATES, December 19, 2024 /⁨EINPresswire.com⁩/ -- Perthera, a leader in AI-driven precision oncology, announces the release of version 4.0 of The Perthera Report®, an innovative decision-support tool that helps oncologists synthesize …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on December 16, 2024 - 20:39 GMT

  Perthera Finds Survival Differences in Lung vs. Liver Metastasis in New Study

  MCCLEAN, VA, UNITED STATES, December 16, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveiled groundbreaking research on Pancreatic Ductal Adenocarcinoma (PDAC) that links survival outcomes to the …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on November 25, 2024 - 21:25 GMT

  

  PERTHERA ANNOUNCES LANDMARK STUDY SHOWING MULTI-OMIC TESTING’S ROLE IN IMPROVING OUTCOMES FOR METASTATIC BREAST CANCER

  MCLEAN, VA, UNITED STATES, November 25, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support, in collaboration with researchers from George Mason University and The Side-Out Foundation, announces the publication …

  Distribution channels: Business & Economy, Companies ...
• Published on November 7, 2024 - 22:53 GMT

  

  Perthera, the Leading Therapeutic Intelligence Company, Releases vMTB 4.0, Accelerating AI Learning

  MCLEAN, VA, UNITED STATES, November 7, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support, announces the release of the latest version of its patented Virtual Molecular Tumor Board application, vMTB 4.0. The …

  Distribution channels: Business & Economy, Companies ...
• Published on July 10, 2024 - 14:00 GMT

  

  Perthera Names Marketing Veteran, Jeanne M. Cummins, Chief Marketing Officer (CMO)

  Appointment Drives Growth and Market Expansion with Strategic Leadership for Perthera, a Pioneer in Precision Oncology Decision Support MCLEAN, VA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- Perthera, The Therapeutic Intelligence Company® and …

  Distribution channels: Business & Economy, Companies ...
• Published on May 31, 2024 - 13:53 GMT

  

  At ASCO ’24, Perthera Launches New Services Aimed at Easing Burden on Clinicians Delivering Precision Oncology Care

  CHICAGO, IL, UNITED STATES, May 31, 2024 /⁨EINPresswire.com⁩/ -- Perthera has announced the addition of new services and capabilities to its Precision Oncology Platform suite aimed at making it easier for Oncologists to identify and deliver the best …

  Distribution channels: Business & Economy, Companies ...
• Published on April 24, 2024 - 16:26 GMT

  

  Renowned Oncologist and Cancer Researcher, Dr. Derek Raghavan, Joins Perthera as Chief Medical Officer

  MCLEAN, VA, UNITED STATES, April 24, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support announces that Dr. Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, founding President of the Levine Cancer Institute and …

  Distribution channels: Business & Economy, Companies ...
• Published on April 2, 2024 - 19:24 GMT

  

  Perthera Names HealthTech and Medical Marketing Veteran, Donna Tuths, as CEO

  Appointment signals new phase of expansion for Perthera, a Pioneer in Precision Oncology Decision Support MCLEAN, VA, UNITED STATES, April 2, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support announces the …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on January 18, 2024 - 20:44 GMT

  

  Precision Oncology Pioneer, Perthera, Presents Latest Research at ASCO GI 2024

  Perthera’s unique GI cancer-focused database helps identify new predictive signatures MCLEAN, VA, UNITED STATES, January 18, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support will be sharing its latest paper …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 8, 2023 - 01:27 GMT

  

  Perthera.ai Announces a Category III CPT Code from the AMA for Its Patented Precision Oncology Decision Support Platform

  The release of a Category III CPT code provides a critical pathway to reimbursement for Perthera’s AI-assisted decision support tool for oncologists. MCLEAN, VA, UNITED STATES, February 8, 2023 /⁨EINPresswire.com⁩/ -- Perthera.ai, the industry leader in …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...